7,104,500 Equity shares of Nidan Laboratories and Healthcare Limited are subject to a Lock-Up Agreement Ending on 9-NOV-2022. These Equity shares will be under lockup for 363 days starting from 11-NOV-2021 to 9-NOV-2022.

Details:
Pursuant to Regulations 236 and 238 of the SEBI (ICDR) Regulations, an aggregate of 20% of the fully diluted post-Issue Equity Share capital of the Company held by the Promoter shall be provided towards minimum Promoter' contribution and locked-in for a period of three years from the date of Allotment.

In addition to Minimum Promoter' Contribution which shall be locked-in for three years, the balance Equity Shares held by Promoter shall be locked in for a period of one year from the date of allotment in the Initial Public Offer as provided in clause (b) of Regulation 238 of the SEBI (ICDR) Regulations, 2018.